JPMorgan Chase & Co. Reiterates “Hold” Rating for CME Group (CME)
CME Group (NYSE:CME)‘s stock had its “hold” rating restated by analysts at JPMorgan Chase & Co. in a research report issued to clients and investors on Tuesday. They currently have a $67.50 price target on the stock, down from their previous price target of $69.50. JPMorgan Chase & Co.’s price target points to a potential downside of 4.40% from the stock’s previous close.
In other CME Group news, CEO Phupinder Gill sold 49,000 shares of CME Group stock on the open market in a transaction dated Monday, June 2nd. The stock was sold at an average price of $71.66, for a total value of $3,511,340.00. The transaction was disclosed in a filing with the SEC, which is available at this link.
CME Group (NYSE:CME) traded down 0.82% during mid-day trading on Tuesday, hitting $70.03. The stock had a trading volume of 1,274,134 shares. CME Group has a one year low of $66.44 and a one year high of $84.71. The stock has a 50-day moving average of $70.42 and a 200-day moving average of $74.66. The company has a market cap of $23.516 billion and a P/E ratio of 23.54.
CME Group (NYSE:CME) last announced its earnings results on Thursday, May 1st. The company reported $0.83 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.83. The company had revenue of $777.00 million for the quarter, compared to the consensus estimate of $368.13 million. During the same quarter in the previous year, the company posted $0.73 earnings per share. The company’s revenue for the quarter was up 8.1% on a year-over-year basis. On average, analysts predict that CME Group will post $3.33 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which is scheduled for Wednesday, June 25th. Stockholders of record on Tuesday, June 10th will be paid a dividend of $0.47 per share. This represents a $1.88 annualized dividend and a dividend yield of 2.66%. The ex-dividend date is Friday, June 6th.
Several other analysts have also recently commented on the stock. Analysts at Zacks downgraded shares of CME Group from a “neutral” rating to an “underperform” rating in a research note on Monday. They now have a $63.00 price target on the stock. Separately, analysts at Jefferies Group reiterated a “buy” rating on shares of CME Group in a research note on Friday, May 9th. They now have a $84.00 price target on the stock, down previously from $89.00. Finally, analysts at Barclays reiterated an “equal weight” rating on shares of CME Group in a research note on Friday, May 2nd. They now have a $78.00 price target on the stock. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and seven have issued a buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of $77.18.
CME Group Inc (NYSE:CME) offer a range of global products across all asset classes based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, metals, weather and real estate.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.